Revvity Inc (BSP:R1VT34)
R$ 23.77 0 (0%) Market Cap: 81.00 Bil Enterprise Value: 93.46 Bil PE Ratio: 56.19 PB Ratio: 1.79 GF Score: 65/100

PerkinElmer Inc at Stifel Virtual Healthcare Conference Transcript

Nov 17, 2020 / 06:20PM GMT
Release Date Price: R$25.07
Daniel Anthony Arias
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst

Okay. Welcome back to day 2 of the 2020 Stifel Healthcare Conferences. This is the life sciences and diagnostics track. Our next company is PerkinElmer. We're happy to have Jamie Mock, the CFO; and Bryan Kipp, the Head of IR, on with us today. Gentlemen, thanks for hopping on with us.

James M. Mock
PerkinElmer, Inc. - Senior VP & CFO

Good to be here. Hope you're doing well, Dan.

Daniel Anthony Arias
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst

Yes. We sure are. Making our way through this conference here. And I think it's probably a good time to talk about the PerkinElmer business. I mean the life sciences space, in general, has got a lot of good things going on. There are certainly interesting parts of your portfolio right now that are quite in vogue, and then others where we're trying to figure out what we have here. So what I'd like to do is spend some

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot